Portuguese austerity measures target medicine prices
This article was originally published in Scrip
New measures published in Portugal's official journal aim to increase domestic access to medicines, stimulate the uptake of generics and make the reimbursement system more efficient. Both the generic medicines and the R&D-based industry sectors have criticised the measures.
You may also be interested in...
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.
Patient access schemes have helped the Scottish Medicines Consortium recommend rare disease products, including Regeneron/Sanofi’s Libtayo for skin cancer.